Neurocrine Biosciences (NBIX) Misses Q1 EPS by 7c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $140.44 +1.47%
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
OCCI, PMCB, BRID, More
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of $0.70, $0.07 worse than the analyst estimate of $0.77. Revenue for the quarter came in at $572.6 million versus the consensus estimate of $593.71 million.
GUIDANCE
INGREZZA Net Product Sales between $2.5-2.6 billion
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Financial Group (JEF) Tops Q3 EPS by 8c
- Vail Resorts (MTN) Tops Q4 EPS by 1c, Offers Guidance
- Anthropic Fy25 Gaap Net Loss Expands To $41.97 Bln Vs $8.31 Bln In Fy24, Prospectus Shows - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
